Fair Value Calculator Fair Value Calculator
EN DE

GUJALKALI (GUJALKALI) Fair Value & Analysis

Basic Materials · Market cap ₹45.0B

G GUJALKALI GUJALKALI · NSE
Price₹612.75
Fair Value₹473.59
Upside-22.7%
Quality58/100
Watch GUJALKALI for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹353.43 – ₹634.69

Fair value as of: Jul 3, 2026

From 13 valuation models · updated today

Share price −7.8% over the past month.

Price vs Fair Value (12 months)

₹801.60 ₹414.15 Fair Value ₹473.59 Jul 2025 Jul 2026

12‑month range ₹414.15 – ₹801.60 · fair‑value band ₹353.43 – ₹634.69 · the ₹612.75 price screens above the ₹473.59 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

GUJALKALI (GUJALKALI) currently trades at ₹612.75, while our model-based Fair Value estimate is ₹473.59 — implying the stock looks roughly 22.7% overvalued today. We read business quality at 58/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, GUJALKALI generated revenue of ₹21.8B at a net margin of 18.4%. It earns a return on equity of -1.1%. Net debt stands at ₹4.0B. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹21.8B
Revenue growth (YoY) +396%
Net margin 18.4%
Return on equity -1.1%
Free cash flow ₹1.5B FY2026
Operating margin 29.2%
More key figures
EPS (TTM) ₹-0.3000
EPS growth (YoY) +519%
Net debt ₹4.0B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

GUJALKALI reported revenue of ₹43.6B in FY2026 versus ₹36.9B in FY2022, a compound +4.2%/yr. Reported net income was −₹24.1M in FY2026.

Revenue +4.2%/yr
FY22 ₹36.9B
FY23 ₹45.2B
FY24 ₹37.8B
FY25 ₹40.7B
FY26 ₹43.6B
Net income
FY22 ₹5.6B
FY23 ₹4.1B
FY24 −₹2.4B
FY25 −₹651M
FY26 −₹24.1M

Is GUJALKALI fairly valued? → Check now

Similar stocks

6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN €448.00 €191.66 -57%
Shin-Etsu Chemical Co SHECY $22.77 $13.22 -42%
BASF SE BAS €50.82 €9.45 -81%
Ningxia Baofeng Energy Group 600989 ¥21.72 ¥42.42 +95%
Dow Inc D1OW34 R$43.91 R$31.57 -28%
Ganfeng Lithium Group 002460 ¥65.65 ¥18.75 -71%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is GUJALKALI (GUJALKALI) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹473.59 versus a price of ₹612.75 — about −23% (overvalued). Model-based estimate, not financial advice.
What is the fair value of GUJALKALI?
Our model-based fair value for GUJALKALI is ₹473.59 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹612.75.
What is the quality score of GUJALKALI?
GUJALKALI has a Quality Score of 58/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of GUJALKALI (GUJALKALI)?
GUJALKALI reported trailing-twelve-month revenue of about ₹21.8B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of GUJALKALI?
The net profit margin of GUJALKALI is about 18.4%, meaning it keeps roughly 18.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.